0
Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

¿ôÀ½Ä¡·á°¡ Áß³â±â ¿©¼ºÀÇ ¼¼·ÎÅä´Ñ, ¿ì¿ï ¹× »îÀÇ Áú¿¡ ¹ÌÄ¡´Â ¿µÇâ°ú °æ·ÎºÐ¼®

Effect and Path Analysis of Laughter Therapy on Serotonin, Depression and Quality of Life in Middle-aged Women

Journal of Korean Academy of Nursing 2015³â 45±Ç 2È£ p.221 ~ 230
KMID : 0806120150450020221
Â÷¹Ì¿¬ ( Cha Mi-Youn ) - À§´ö´ëÇб³ °£È£Çаú

È«Çؼ÷ ( Hong Hae-Sook ) - °æºÏ´ëÇб³ °£È£´ëÇÐ

Abstract

Purpose: This study was done to examine how laughter therapy impacts serotonin levels, QOL and depression in middle-aged women and to perform a path analysis for verification of the effects.

Methods: A quasi-experimental study employing a nonequivalent control group and pre-post design was conducted. Participants were 64 middle-aged women (control=14 and experimental=50 in 3 groups according to level of depression). The intervention was conducted five times a week for a period of 2 weeks and the data analysis was conducted using repeated measures ANOVA, ANCOVA and LISREL.

Results: Results showed that pre serotonin and QOL in women with severe depression were the lowest. Serotonin in the experimental groups increased after the 10th intervention (p=.006) and the rise was the highest in the group with severe depression (p=.001). Depression in all groups decreased after the 5th intervention (p=.022) and the biggest decline was observed in group with severe depression (p=.007). QOL of the moderate and severe groups increased after the 10th intervention (p=.049), and the increase rate was highest in group with severe depression (p<.006). Path analysis revealed that laughter therapy did not directly affect depression, but its effect was indirectly meditated through serotonin variation (p<.001).

Conclusion: Results indicate that serotonin activation through laughter therapy can help middle-aged women by lessening depression and providing important grounds for depression control.
KeyWords
¿ôÀ½Ä¡·á, Áß³â±â ¿©¼º, ¼¼·ÎÅä´Ñ, ¿ì¿ï, »îÀÇ Áú
Laughter therapy, Middle-aged women, Serotonin, Depression, Quality of life
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
 
µîÀçÀú³Î Á¤º¸
SCI(E) MEDLINE ÇмúÁøÈïÀç´Ü(KCI) KoreaMed